Abstract
The study examined the extent of clinical recognition of comorbid substance use disorders and the clinical management of these disorders among inpatients hospitalized for an acute exacerbation of schizophrenia. Medical records of 42 inpatients who met research diagnostic criteria for both schizophrenia and a current substance use disorder were reviewed for information about admission evaluation, inpatient management, discharge diagnosis, and disposition. Alcohol use disorders were the most frequent co-occurring substance-related diagnoses, found for 86 percent of the dually diagnosed inpatients. Twenty-four patients (57 percent) did not receive a diagnosis of a substance-related disorder at admission, and 19 (45 percent) did not receive a substance-related diagnosis at discharge. Referral to inpatient or outpatient substance abuse treatment was documented for a minority of subjects. The results suggest that improvements are needed in the process of clinical care for inpatients with schizophrenia who have co-occurring substance-related disorders. They highlight a need for education of health care providers and continuous quality improvement in this area.
Citations
Mar 29, 2001·The American Journal of Orthopsychiatry·S P Segal, E A Dittrich
Jun 7, 2006·Administration and Policy in Mental Health·Alisa B BuschShelly F Greenfield
Mar 28, 2009·Schizophrenia Bulletin·Nora D Volkow
Feb 16, 2007·Schizophrenia Research·Victoria ManningMichael Gossop
May 9, 2006·Addictive Behaviors·Melanie E BennettJean S Gearon
Aug 25, 2007·Annual Review of Clinical Psychology·Howard N Garb
Jan 5, 2002·Journal of Substance Abuse Treatment·K H LittrellC G Johnson
Jul 6, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·P Batel
Jan 5, 2002·Journal of Addictive Diseases·J ModestinS Christen
May 21, 1999·The Australian and New Zealand Journal of Psychiatry·N SiegfriedJ M Rey
Feb 7, 2009·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Cheryl IrmiterFredrick C Blow
May 10, 2013·Harvard Review of Psychiatry·David N OsserTheo Manschreck
Oct 7, 2017·Journal of Clinical Psychopharmacology·Thomas BeresfordPatrick J Ronan
Jan 19, 2000·The Journal of the American Academy of Psychiatry and the Law·R Sinha, C Easton
Jun 8, 2000·Medical Care·E P FischerG M Curran